Spio-MR Imaging versus Double-Phase Spiral CT in Detecting Malignant Lesions of the Liver

References

• Baron R. L. Understanding and optimizing use of contrast material for CT of the liver. AJR 1994; 163: 323
   PubMed Web of Science ®Google Scholar
• Bellin M. F., Zaim S., Auberton E., et al. Liver metastases. Safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 1994; 193: 657
   PubMed Web of Science ®Google Scholar
• Blakeborough A., Ward J., Wilson D., et al. Hepatic lesion detection at MR imaging. A comparative study with four sequences. Radiology 1997; 203: 759
   Google Scholar
• Choi B. I., Han J. K., Cho J. M., et al. Characterization of focal hepatic tumors (value of two-phase computed tomography). Cancer 1995; 12: 2434
   Google Scholar
• Edelmann R. R., Siegel J. B., Singer A., Dupuis K., Longmaid H. E. Dynamic MR imaging of the liver with Gd-DTPA. Initial clinical results. AJR 1989; 153: 1213
   PubMed Web of Science ®Google Scholar
• Fishbein M., Long F., Smith M. Fast gradient echo MR imaging of the liver enhanced with superparamagnetic iron oxide. Magn. Reson. Imaging 1997; 15: 651
   Google Scholar
• Frederick M. G., Paulson E. K., Nelson R. C. Helical CT for detecting focal liver lesions in patients with breast carcinoma. Comparison of noncontrast phase, hepatic arterial phase and portal venous phase. J. Comput. Assist. Tomogr. 1997; 21: 229
   Google Scholar
• Fretz C. J., Stark D. D., Metz C. E., et al. Detection of hepatic metastases. Comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AJR 1990; 155: 763
   Google Scholar
• Gaa J., Fischer H., Laub G., Georgi M. Breath-hold MR imaging of focal liver lesions. Comparison of fast and ultrafast techniques. Eur. Radiol. 1996; 6: 838
   Google Scholar
• Grangier C., Tourniaire J., Mentha G., et al. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles. J. Comput. Assist. Tomogr. 1994; 18: 888
   PubMed Web of Science ®Google Scholar
• Hagspiel K. D., Neidl K. F. W., Eichenberger A. C., Weder W., Marincek B. Detection of liver metastases. Comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995; 196: 471
   PubMed Web of Science ®Google Scholar
• Halavaara J., Lamminen A. E., Bondesstam S., Standertskjöld-Nordenstam C. G., Hamberg L. M. Detection of focal liver lesions with superparamagnetic iron oxide. Value of STIR and SE imaging. J. Comput. Assist. Tomogr. 1994; 18: 897
   PubMed Web of Science ®Google Scholar
• Hamm B., Reichel M., Vogl T., Taupitz M., Wolf K. G. Superparamagnetische Eisenpartikel. RÖFO 1994; 160: 52
   Google Scholar
• Hollett M. D., Jeffrey R. B., Nino-Murcia M., Jorgensen M. J., Harris D. P. Dual-phase helical CT of the liver. Value of arterial phase scans in the detection of small (<1.5 cm) malignant hepatic neoplasms. AJR 1995; 164: 879
   Google Scholar
• Hruby W., Stellamor K. Kontrastmittelverhalten von Lebertumoren in CT-Korrelation zwischen Pharmakokinetik und feingeweblichem Bau. Röntgenblätter 1988; 41: 133
   Google Scholar
• Jung G., Krahe T., Kugel H., et al. Prospective comparison of fast SE and GRASE sequences and echo planar imaging with conventional SE sequences in the detection of focal liver lesions at 1.0 T. J. Comput. Assist. Tomogr. 1997; 21: 341
   Google Scholar
• Marchal G., Van Hecke P., Demaerel P., et al. Detection of liver metastases with superparamagnetic iron oxide in 15 patients. Results of MR imaging at 1.5 T. AJR 1989; 152: 771
   PubMed Web of Science ®Google Scholar
• Oestmann J. W., Galanski M. Methodik zum Vergleich der diagnostischen Leistung bildgebender Verfahren. RÖFO 1989; 151: 89
   Google Scholar
• Oliver J. H., Baron R. L., Federle M. P., Rockette H. E. Detecting hepatocellular carcinoma. Value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR 1996; 167: 71
   Google Scholar
• Oudkerk M., van den Heuvel A. G., Wielpolski P. A., Schmitz P. I., Borel-Rinkes I. H., Wiggers T. Hepatic lesions. Detction with ferrumoxide-enhanced T1-weighted MR imaging. Radiology 1997; 203: 449
   PubMedGoogle Scholar
• Ros P. R., Feeny P. C., Harms S. E., et al. Hepatic MR imaging with ferrumoxides. A multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995; 196: 481
   PubMed Web of Science ®Google Scholar
• Varianzanalytische Methoden. Angewandte Statistik, L. Sachs. Springer-Verlag, Berlin 1992; 612
   Google Scholar
• Saini S., Stark D. D., Hahn P. F., Wittenberg J., Brady T. J., Ferruci J. T. Ferrite particles. A superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology 1987; 162: 211
   PubMed Web of Science ®Google Scholar
• Saini S., Stark D. D., Hahn P. F., et al. Ferrite particles. A superparamagnetic MR contrast agent for enhanced detection of liver carcinoma. Radiology 1987; 162: 217
   PubMed Web of Science ®Google Scholar
• Schwartz L. H., Seltzer S. E., Adams D. F., et al. Effects of superparamagnetic iron oxide (AMI-25) on liver and spleen imaging using spin-echo and fast spin-echo magnetic resonance pulse sequences. Invest. Radiol. 1994; 29: 21
   Google Scholar
• Stark D. D., Weissleder R., Elizando G., et al. Superparamagnetic iron oxide. Clinical application as a contrast agent for MR imaging of the liver. Radiology 1988; 168: 297
   PubMed Web of Science ®Google Scholar
• Suto Y., Kodama F., Kamba M., Ohta Y. Correlation between chondroitin sulfate iron colloid-enhanced MR imaging and the histological grade of hepatocellular carcinoma. Acta Radiol. 1995; 36: 102
   PubMed Web of Science ®Google Scholar
• Taylor P. M., Hawnaur J. M., Hutchinson C. E. Superparamagnetic iron oxide imaging of focal liver disease. Clin. Radiol. 1995; 50: 215
   PubMed Web of Science ®Google Scholar
• Urhahn R., Adam G., Busch N., Chen J. H., Euringer W., Günther R. W. Superparamagnetische Eisenoxidpartikel. Welchen Stellenwert hat der T1-Effekt für die MR-Diagnostik fokaler Leberläsionen?. RÖFO 1996; 165: 364
   Google Scholar
• van-Gansbeke D., Metens T. M., Matos C., et al. Effects of AMI-25 on liver vessels and tumors on T1-weighted turbo-field-echo images. Implications for tumor characterization. J. Magn. Reson. Imaging 1997; 7: 482
   Google Scholar
• Van Hoe L., Bosmans H., Aerts P., et al. Focal liver lesions. Fast T2-weighted MR imaging with half-Fourier rapid acquisition with relaxation enhancement. Radiology 1996; 201: 817
   Google Scholar
• Vogl T. J., Hammerstingl R., Pegios W., et al. Wertigkeit des leberspezifischen superparamagnetischen Kontrastmittels AMI-25 für die Detektion und Differentialdiagnose lebereigener Tumoren versus Metastasen. RÖFO 1994; 160: 319
   PubMedGoogle Scholar
• Weissleder R., Stark D. D., Engelstadt D. L., et al. Superparamagnetic iron oxide. Pharmacokinetics and toxicity. AJR 1989; 152: 167
   PubMed Web of Science ®Google Scholar
• Winter T. C., Freeny P. C., Nghiem H. V., et al. MR imaging with superparamagnetic iron oxide efficacy in the detection of focal hepatic lesions. AJR 1993; 161: 1191
   PubMed Web of Science ®Google Scholar
• Yamamoto H., Yamashita Y., Yoshimatsu S., et al. Hepatocellular carcinoma in cirrhotic livers. Detection with unenhanced and iron oxide-enhanced MR imaging. Radiology 1995; 195: 106
   Google Scholar
• Zwicker C., Langer M., Astinet F., Langer R., Ulrich V., Felix R. Differenzierung maligner Lebertumoren mit schneller dynamischer CT. RÖFO 1990; 152: 293
   Google Scholar